34.50
3.09%
-1.10
Pre-market:
34.72
0.22
+0.64%
Rxsight Inc stock is traded at $34.50, with a volume of 439.90K.
It is down -3.09% in the last 24 hours and down -13.05% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$35.60
Open:
$35.59
24h Volume:
439.90K
Relative Volume:
0.73
Market Cap:
$1.39B
Revenue:
$115.18M
Net Income/Loss:
$-36.77M
P/E Ratio:
-34.16
EPS:
-1.01
Net Cash Flow:
$-35.35M
1W Performance:
-0.14%
1M Performance:
-13.05%
6M Performance:
-39.46%
1Y Performance:
-25.10%
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
34.50 | 1.39B | 115.18M | -36.77M | -35.35M | -1.01 |
ABT
Abbott Laboratories
|
114.25 | 198.16B | 41.22B | 5.77B | 6.49B | 3.29 |
BSX
Boston Scientific Corp
|
95.95 | 141.41B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
364.10 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
82.68 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
74.15 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-20-24 | Downgrade | Stifel | Buy → Hold |
Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Dec-06-24 | Initiated | UBS | Buy |
Oct-29-24 | Initiated | Jefferies | Buy |
Aug-20-24 | Reiterated | Needham | Buy |
Aug-06-24 | Reiterated | Needham | Buy |
May-07-24 | Reiterated | BTIG Research | Buy |
Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Dec-12-23 | Initiated | Stifel | Buy |
Dec-04-23 | Initiated | Morgan Stanley | Overweight |
Apr-13-23 | Initiated | Oppenheimer | Outperform |
Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
How the (RXST) price action is used to our Advantage - Stock Traders Daily
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 2.8% loss over the past year - Simply Wall St
RxSight, Inc. To Present At The J.P. Morgan Healthcare Conference - Barchart
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - The Manila Times
RxSight (NASDAQ:RXST) Hits New 1-Year LowHere's Why - MarketBeat
Trading (RXST) With Integrated Risk Controls - Stock Traders Daily
Geode Capital Management LLC Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Purchased by Geode Capital Management LLC - MarketBeat
Barclays PLC Acquires 46,783 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Barclays PLC - Defense World
MML Investors Services LLC Invests $452,000 in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight (NASDAQ:RXST) Cut to Hold at Stifel Nicolaus - Defense World
RxSight (NASDAQ:RXST) Sets New 12-Month Low – What’s Next? - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Bought by State Street Corp - MarketBeat
RxSight cut to hold at Stifel on competition concerns - MSN
RxSight stock touches 52-week low at $34.68 amid market shifts - Investing.com Australia
Stifel Downgrades RxSight (RXST) - MSN
Midday Stock Roundup: Mullen Down 10% Since Last Week’s Sales Update - Orange County Business Journal
RxSight Enters Oversold Territory (RXST) - Nasdaq
RxSight stock cut to hold at Stifel (RXST:NASDAQ) - Seeking Alpha
RxSight (NASDAQ:RXST) Reaches New 52-Week LowShould You Sell? - MarketBeat
RxSight stock touches 52-week low at $34.68 amid market shifts By Investing.com - Investing.com South Africa
Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? - Insider Monkey
Forecasting The Future: 4 Analyst Projections For RxSight - Benzinga
Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year - Yahoo Finance
HighTower Advisors LLC Purchases 3,571 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel downgrades RxSight stock on slowing LAL adoption projections - Investing.com
Stifel Downgrades RxSight Inc. (RXST) to Hold - StreetInsider.com
RxSight (NASDAQ:RXST) Trading Down 0.7%What's Next? - MarketBeat
RxSight (NASDAQ:RXST) Trading 3.7% HigherWhat's Next? - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Lord Abbett & CO. LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Up 1.3%Should You Buy? - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 1.6%Here's Why - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 4.8%Should You Sell? - MarketBeat
Wells Fargo cuts RxSight rating, sees limited growth potential By Investing.com - Investing.com Nigeria
RxSight (NASDAQ:RXST) Shares Gap DownHere's Why - MarketBeat
Wells Fargo cuts RxSight rating, sees limited growth potential - Investing.com
RxSight (NASDAQ:RXST) Given "Equal Weight" Rating at Wells Fargo & Company - MarketBeat
RxSight downgraded to Equal Weight from Overweight at Wells Fargo - TipRanks
RxSight (NASDAQ:RXST) Trading Down 1.9%Here's What Happened - MarketBeat
Two Sigma Advisers LP Sells 119,200 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 0.1%What's Next? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 62,507 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Research Coverage Started at UBS Group - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Fmr LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Down 2%Time to Sell? - MarketBeat
UBS Initiates Coverage of RxSight (RXST) with Buy Recommendation - Nasdaq
UBS bullish on RxSight stock, projects 20%+ sales growth through 2028 - Investing.com Nigeria
RxSight Inc (RXST) Stock Price Up 3.84% on Dec 6 - GuruFocus.com
RxSight (NASDAQ:RXST) Coverage Initiated at UBS Group - MarketBeat
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):